GSK will invest in new manufacturing facilities in Ware for its Relvar (zanamivir) Ellipta used for respiratory disease. The Ellipta device was developed at Ware and will now be produced at the site ...

F ollowing outlays for sites in the UK and Belgium earlier this year, GSK is planning to invest up to $800m in the US to double the size and capacity of its site in Marietta, ... (MAPS) technology ...

The FINANCIAL — GSK on April 18 opens a £56 million state of the art manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory ...

Proactive Investors - GSK PLC (LON:GSK) has opened a new £65 million drug factory in Hertfordshire in a move it said would enable rapid production of medicines developed through its research pipeline.

LONDON (Alliance News) - GlaxoSmithKline PLC said Monday it is opening a new GBP56 million respiratory manufacturing facility in Ware, which it said will create 150 new jobs in the UK. The new ...

Around £74m will also invested at the firm’s site in Ware, ... GlaxoSmithKline currently employs 16,000 people in the UK, 6,000 of whom work in manufacturing across a total of nine bases.

A major pharmaceutical firm is to invest £110m developing its operations at its site in Angus. GlaxoSmithKline (GSK) is to build a state of the art production facility at Montrose to manufacture ...

GSK has nine sites in the UK employing approximately 6,000 people. The Barnard Castle site in County Durham is one of GSK’s biggest secondary manufacturing sites, employing 1,100 people.